tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Lee Lueder, 5 are a HOLD (33.33%), 10 are a BUY (66.67%).
Analyst Lee Lueder, carries an average stock price target met ratio of 83.81% that have a potential upside of 18.89% achieved within 100 days.
Lee Lueder’s has documented 29 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 22-Mar-2024.
Analyst best performing recommendations are on IQV (IQVIA HOLDINGS).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 11/9/2023. The price target of $215 was fulfilled within 34 days with a profit of $45.53 (26.87%) receiving and performance score of 7.9.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 07-Jun-2024
$200
$-2.42 (-1.20%)
$174
22 days ago
(18-Dec-2025)
6/6 (100%)
$6.15 (3.17%)
44
Buy
Since 02-Oct-2025
$215
$12.58 (6.21%)
$210
25 days ago
(15-Dec-2025)
7/9 (77.78%)
$21.97 (11.38%)
50
Hold
Since 08-Aug-2024
$190
$-12.42 (-6.14%)
$160
25 days ago
(15-Dec-2025)
4/5 (80%)
$-3.03 (-1.57%)
17
Hold
Since 28-Jun-2024
1 months 23 days ago
(17-Nov-2025)
5/7 (71.43%)
$27.87 (10.63%)
136
Buy
Since 10-Nov-2025
$197
$-5.42 (-2.68%)
$105
1 months 30 days ago
(10-Nov-2025)
8/9 (88.89%)
$28.03 (16.59%)
91
What Year was the first public recommendation made by Lee Lueder?
